Zhen Luo

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 496 citations

Medicine, Pharmacology, Pharmacotherapy +12

The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis

D L Boyle, K. Soma, J Hodge et al. · Annals of the Rheumatic Diseases · 2014 · 298 citations · Full text

Medicine, Pathobiology, Pharmacology +17

Potential Mechanisms Leading to the Abnormal Lipid Profile in Patients With Rheumatoid Arthritis Versus Healthy Volunteers and Reversal by Tofacitinib

Christina Charles‐Schoeman, Roy Fleischmann, Jean Davignon et al. · Arthritis & Rheumatology · 2014 · 185 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study*

Iain B. McInnes, Ho‐Youn Kim, Sang‐Heon Lee et al. · Annals of the Rheumatic Diseases · 2013 · 125 citations

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of HSK3486 for Anesthesia/Sedation in Patients Undergoing Fiberoptic Bronchoscopy: A Multicenter, Double-Blind, Propofol-Controlled, Randomized, Phase 3 Study

Zhen Luo, Hong Tu, Xiang Zhang et al. · CNS Drugs · 2022 · 92 citations · Full text

Medicine, Anesthesiology, Pharmacokinetics +13